You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

No description, website, or topics provided.

Shares of Hikma Pharmaceuticals stock opened at GBX 2,123.65 ($27.45) on Friday. The stock has a market capitalization of £5.89 billion, a P/E ratio of 20.84, a PEG ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals reported a strong financial performance for 2024, with revenue rising nine per cent to $3.13bn (£2.47bn) and operating profit up 67 per cent to $612m (£483m). Profit ...

Group core revenue up 10%, including contribution from Xellia acquisition (9% organic). Reported Group revenue up 9% Core revenue up in all three business segments – Injectables up 10%, Branded up 8% ...

Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents on Novo Nordisk’s (NVO) diabetes and weight loss ...

Muslim scientists had developed their own perceptions, meanings and worldviews of knowledge that differ drastically from ...

Ramallah - The Bayt Mal Al-Quds Agency, the Palestinian Ministry of Culture, and the National Library of Palestine signed a partnership agreement on Monday in Ramallah, aimed at supporting cultural ...

Amman, Jordan: Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2024. The Group reported revenue growth of 9% (9% ...